Alzheimer's Disease (AD) blood diagnostic refers to a clinical test or series of tests that analyze specific biomarkers present in the blood to identify and diagnose Alzheimer's Disease. These diagnostics aim to detect the presence of pathological changes associated with AD, such as amyloid plaques, tau tangles, neurodegeneration, and other related abnormalities, using minimally invasive blood samples.

Alzheimer's Disease blood diagnostics represent a promising advancement in the field of neurodegenerative disease detection. By leveraging specific biomarkers and advanced analytical techniques, these tests offer a non-invasive, accessible, and potentially cost-effective means of diagnosing and monitoring Alzheimer's Disease, ultimately improving patient outcomes through earlier and more accurate diagnosis.

The global Alzheimer's Disease Blood Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Alzheimer's Disease Blood Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Alzheimer's Disease Blood Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Alzheimer's Disease Blood Diagnostic in Early Diagnosis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Alzheimer's Disease Blood Diagnostic include Quanterix, C2N Diagnostics, Sysmex, Quest Diagnostics, Roche Diagnostics, Eli Lilly and Company, Fujirebio, Amoneta Diagnostics, MagQu, Vazyme, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Blood Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Blood Diagnostic.

The Alzheimer's Disease Blood Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alzheimer's Disease Blood Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Alzheimer's Disease Blood Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Alzheimer's Disease Blood Diagnostic Market Report

Report Metric	Details
Report Name	Alzheimer's Disease Blood Diagnostic Market
Segment by Type	Amyloid Beta (Aβ) Tau Proteins Others
Segment by Application	Early Diagnosis Clinical Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Quanterix, C2N Diagnostics, Sysmex, Quest Diagnostics, Roche Diagnostics, Eli Lilly and Company, Fujirebio, Amoneta Diagnostics, MagQu, Vazyme, KingMed Diagnostics, Anqun Bioengineering
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer's Disease Blood Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Alzheimer's Disease Blood Diagnostic Market report?

Ans: The main players in the Alzheimer's Disease Blood Diagnostic Market are Quanterix, C2N Diagnostics, Sysmex, Quest Diagnostics, Roche Diagnostics, Eli Lilly and Company, Fujirebio, Amoneta Diagnostics, MagQu, Vazyme, KingMed Diagnostics, Anqun Bioengineering

What are the Application segmentation covered in the Alzheimer's Disease Blood Diagnostic Market report?

Ans: The Applications covered in the Alzheimer's Disease Blood Diagnostic Market report are Early Diagnosis, Clinical Research

What are the Type segmentation covered in the Alzheimer's Disease Blood Diagnostic Market report?

Ans: The Types covered in the Alzheimer's Disease Blood Diagnostic Market report are Amyloid Beta (Aβ), Tau Proteins, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Amyloid Beta (Aβ)

1.2.3 Tau Proteins

1.2.4 Others

1.3 Market by Application

1.3.1 Global Alzheimer's Disease Blood Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Early Diagnosis

1.3.3 Clinical Research

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Alzheimer's Disease Blood Diagnostic Market Perspective (2019-2030)

2.2 Global Alzheimer's Disease Blood Diagnostic Growth Trends by Region

2.2.1 Global Alzheimer's Disease Blood Diagnostic Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Alzheimer's Disease Blood Diagnostic Historic Market Size by Region (2019-2024)

2.2.3 Alzheimer's Disease Blood Diagnostic Forecasted Market Size by Region (2025-2030)

2.3 Alzheimer's Disease Blood Diagnostic Market Dynamics

2.3.1 Alzheimer's Disease Blood Diagnostic Industry Trends

2.3.2 Alzheimer's Disease Blood Diagnostic Market Drivers

2.3.3 Alzheimer's Disease Blood Diagnostic Market Challenges

2.3.4 Alzheimer's Disease Blood Diagnostic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Alzheimer's Disease Blood Diagnostic Players by Revenue

3.1.1 Global Top Alzheimer's Disease Blood Diagnostic Players by Revenue (2019-2024)

3.1.2 Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Players (2019-2024)

3.2 Global Alzheimer's Disease Blood Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Alzheimer's Disease Blood Diagnostic Revenue

3.4 Global Alzheimer's Disease Blood Diagnostic Market Concentration Ratio

3.4.1 Global Alzheimer's Disease Blood Diagnostic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Blood Diagnostic Revenue in 2023

3.5 Global Key Players of Alzheimer's Disease Blood Diagnostic Head office and Area Served

3.6 Global Key Players of Alzheimer's Disease Blood Diagnostic, Product and Application

3.7 Global Key Players of Alzheimer's Disease Blood Diagnostic, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Alzheimer's Disease Blood Diagnostic Breakdown Data by Type

4.1 Global Alzheimer's Disease Blood Diagnostic Historic Market Size by Type (2019-2024)

4.2 Global Alzheimer's Disease Blood Diagnostic Forecasted Market Size by Type (2025-2030)

5 Alzheimer's Disease Blood Diagnostic Breakdown Data by Application

5.1 Global Alzheimer's Disease Blood Diagnostic Historic Market Size by Application (2019-2024)

5.2 Global Alzheimer's Disease Blood Diagnostic Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Alzheimer's Disease Blood Diagnostic Market Size (2019-2030)

6.2 North America Alzheimer's Disease Blood Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Alzheimer's Disease Blood Diagnostic Market Size by Country (2019-2024)

6.4 North America Alzheimer's Disease Blood Diagnostic Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Alzheimer's Disease Blood Diagnostic Market Size (2019-2030)

7.2 Europe Alzheimer's Disease Blood Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Alzheimer's Disease Blood Diagnostic Market Size by Country (2019-2024)

7.4 Europe Alzheimer's Disease Blood Diagnostic Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size (2019-2030)

8.2 Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size by Region (2019-2024)

8.4 Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Alzheimer's Disease Blood Diagnostic Market Size (2019-2030)

9.2 Latin America Alzheimer's Disease Blood Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Alzheimer's Disease Blood Diagnostic Market Size by Country (2019-2024)

9.4 Latin America Alzheimer's Disease Blood Diagnostic Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size (2019-2030)

10.2 Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Country (2019-2024)

10.4 Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Quanterix

11.1.1 Quanterix Company Details

11.1.2 Quanterix Business Overview

11.1.3 Quanterix Alzheimer's Disease Blood Diagnostic Introduction

11.1.4 Quanterix Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

11.1.5 Quanterix Recent Development

11.2 C2N Diagnostics

11.2.1 C2N Diagnostics Company Details

11.2.2 C2N Diagnostics Business Overview

11.2.3 C2N Diagnostics Alzheimer's Disease Blood Diagnostic Introduction

11.2.4 C2N Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

11.2.5 C2N Diagnostics Recent Development

11.3 Sysmex

11.3.1 Sysmex Company Details

11.3.2 Sysmex Business Overview

11.3.3 Sysmex Alzheimer's Disease Blood Diagnostic Introduction

11.3.4 Sysmex Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

11.3.5 Sysmex Recent Development

11.4 Quest Diagnostics

11.4.1 Quest Diagnostics Company Details

11.4.2 Quest Diagnostics Business Overview

11.4.3 Quest Diagnostics Alzheimer's Disease Blood Diagnostic Introduction

11.4.4 Quest Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

11.4.5 Quest Diagnostics Recent Development

11.5 Roche Diagnostics

11.5.1 Roche Diagnostics Company Details

11.5.2 Roche Diagnostics Business Overview

11.5.3 Roche Diagnostics Alzheimer's Disease Blood Diagnostic Introduction

11.5.4 Roche Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

11.5.5 Roche Diagnostics Recent Development

11.6 Eli Lilly and Company

11.6.1 Eli Lilly and Company Company Details

11.6.2 Eli Lilly and Company Business Overview

11.6.3 Eli Lilly and Company Alzheimer's Disease Blood Diagnostic Introduction

11.6.4 Eli Lilly and Company Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

11.6.5 Eli Lilly and Company Recent Development

11.7 Fujirebio

11.7.1 Fujirebio Company Details

11.7.2 Fujirebio Business Overview

11.7.3 Fujirebio Alzheimer's Disease Blood Diagnostic Introduction

11.7.4 Fujirebio Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

11.7.5 Fujirebio Recent Development

11.8 Amoneta Diagnostics

11.8.1 Amoneta Diagnostics Company Details

11.8.2 Amoneta Diagnostics Business Overview

11.8.3 Amoneta Diagnostics Alzheimer's Disease Blood Diagnostic Introduction

11.8.4 Amoneta Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

11.8.5 Amoneta Diagnostics Recent Development

11.9 MagQu

11.9.1 MagQu Company Details

11.9.2 MagQu Business Overview

11.9.3 MagQu Alzheimer's Disease Blood Diagnostic Introduction

11.9.4 MagQu Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

11.9.5 MagQu Recent Development

11.10 Vazyme

11.10.1 Vazyme Company Details

11.10.2 Vazyme Business Overview

11.10.3 Vazyme Alzheimer's Disease Blood Diagnostic Introduction

11.10.4 Vazyme Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

11.10.5 Vazyme Recent Development

11.11 KingMed Diagnostics

11.11.1 KingMed Diagnostics Company Details

11.11.2 KingMed Diagnostics Business Overview

11.11.3 KingMed Diagnostics Alzheimer's Disease Blood Diagnostic Introduction

11.11.4 KingMed Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

11.11.5 KingMed Diagnostics Recent Development

11.12 Anqun Bioengineering

11.12.1 Anqun Bioengineering Company Details

11.12.2 Anqun Bioengineering Business Overview

11.12.3 Anqun Bioengineering Alzheimer's Disease Blood Diagnostic Introduction

11.12.4 Anqun Bioengineering Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

11.12.5 Anqun Bioengineering Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Eli Lilly and Company

List of Tables

Table 1. Global Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Amyloid Beta (Aβ)

Table 3. Key Players of Tau Proteins

Table 4. Key Players of Others

Table 5. Global Alzheimer's Disease Blood Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Alzheimer's Disease Blood Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Alzheimer's Disease Blood Diagnostic Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Alzheimer's Disease Blood Diagnostic Market Share by Region (2019-2024)

Table 9. Global Alzheimer's Disease Blood Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Alzheimer's Disease Blood Diagnostic Market Share by Region (2025-2030)

Table 11. Alzheimer's Disease Blood Diagnostic Market Trends

Table 12. Alzheimer's Disease Blood Diagnostic Market Drivers

Table 13. Alzheimer's Disease Blood Diagnostic Market Challenges

Table 14. Alzheimer's Disease Blood Diagnostic Market Restraints

Table 15. Global Alzheimer's Disease Blood Diagnostic Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Alzheimer's Disease Blood Diagnostic Market Share by Players (2019-2024)

Table 17. Global Top Alzheimer's Disease Blood Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Blood Diagnostic as of 2023)

Table 18. Ranking of Global Top Alzheimer's Disease Blood Diagnostic Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Alzheimer's Disease Blood Diagnostic Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Alzheimer's Disease Blood Diagnostic, Headquarters and Area Served

Table 21. Global Key Players of Alzheimer's Disease Blood Diagnostic, Product and Application

Table 22. Global Key Players of Alzheimer's Disease Blood Diagnostic, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Alzheimer's Disease Blood Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Type (2019-2024)

Table 26. Global Alzheimer's Disease Blood Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Type (2025-2030)

Table 28. Global Alzheimer's Disease Blood Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Application (2019-2024)

Table 30. Global Alzheimer's Disease Blood Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Alzheimer's Disease Blood Diagnostic Revenue Market Share by Application (2025-2030)

Table 32. North America Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Alzheimer's Disease Blood Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Alzheimer's Disease Blood Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Alzheimer's Disease Blood Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Alzheimer's Disease Blood Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Alzheimer's Disease Blood Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Alzheimer's Disease Blood Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 47. Quanterix Company Details

Table 48. Quanterix Business Overview

Table 49. Quanterix Alzheimer's Disease Blood Diagnostic Product

Table 50. Quanterix Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024) & (US$ Million)

Table 51. Quanterix Recent Development

Table 52. C2N Diagnostics Company Details

Table 53. C2N Diagnostics Business Overview

Table 54. C2N Diagnostics Alzheimer's Disease Blood Diagnostic Product

Table 55. C2N Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024) & (US$ Million)

Table 56. C2N Diagnostics Recent Development

Table 57. Sysmex Company Details

Table 58. Sysmex Business Overview

Table 59. Sysmex Alzheimer's Disease Blood Diagnostic Product

Table 60. Sysmex Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024) & (US$ Million)

Table 61. Sysmex Recent Development

Table 62. Quest Diagnostics Company Details

Table 63. Quest Diagnostics Business Overview

Table 64. Quest Diagnostics Alzheimer's Disease Blood Diagnostic Product

Table 65. Quest Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024) & (US$ Million)

Table 66. Quest Diagnostics Recent Development

Table 67. Roche Diagnostics Company Details

Table 68. Roche Diagnostics Business Overview

Table 69. Roche Diagnostics Alzheimer's Disease Blood Diagnostic Product

Table 70. Roche Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024) & (US$ Million)

Table 71. Roche Diagnostics Recent Development

Table 72. Eli Lilly and Company Company Details

Table 73. Eli Lilly and Company Business Overview

Table 74. Eli Lilly and Company Alzheimer's Disease Blood Diagnostic Product

Table 75. Eli Lilly and Company Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024) & (US$ Million)

Table 76. Eli Lilly and Company Recent Development

Table 77. Fujirebio Company Details

Table 78. Fujirebio Business Overview

Table 79. Fujirebio Alzheimer's Disease Blood Diagnostic Product

Table 80. Fujirebio Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024) & (US$ Million)

Table 81. Fujirebio Recent Development

Table 82. Amoneta Diagnostics Company Details

Table 83. Amoneta Diagnostics Business Overview

Table 84. Amoneta Diagnostics Alzheimer's Disease Blood Diagnostic Product

Table 85. Amoneta Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024) & (US$ Million)

Table 86. Amoneta Diagnostics Recent Development

Table 87. MagQu Company Details

Table 88. MagQu Business Overview

Table 89. MagQu Alzheimer's Disease Blood Diagnostic Product

Table 90. MagQu Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024) & (US$ Million)

Table 91. MagQu Recent Development

Table 92. Vazyme Company Details

Table 93. Vazyme Business Overview

Table 94. Vazyme Alzheimer's Disease Blood Diagnostic Product

Table 95. Vazyme Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024) & (US$ Million)

Table 96. Vazyme Recent Development

Table 97. KingMed Diagnostics Company Details

Table 98. KingMed Diagnostics Business Overview

Table 99. KingMed Diagnostics Alzheimer's Disease Blood Diagnostic Product

Table 100. KingMed Diagnostics Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024) & (US$ Million)

Table 101. KingMed Diagnostics Recent Development

Table 102. Anqun Bioengineering Company Details

Table 103. Anqun Bioengineering Business Overview

Table 104. Anqun Bioengineering Alzheimer's Disease Blood Diagnostic Product

Table 105. Anqun Bioengineering Revenue in Alzheimer's Disease Blood Diagnostic Business (2019-2024) & (US$ Million)

Table 106. Anqun Bioengineering Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Alzheimer's Disease Blood Diagnostic Picture

Figure 2. Global Alzheimer's Disease Blood Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Alzheimer's Disease Blood Diagnostic Market Share by Type: 2023 VS 2030

Figure 4. Amyloid Beta (Aβ) Features

Figure 5. Tau Proteins Features

Figure 6. Others Features

Figure 7. Global Alzheimer's Disease Blood Diagnostic Market Size by Application (2024-2030) & (US$ Million)

Figure 8. Global Alzheimer's Disease Blood Diagnostic Market Share by Application: 2023 VS 2030

Figure 9. Early Diagnosis Case Studies

Figure 10. Clinical Research Case Studies

Figure 11. Alzheimer's Disease Blood Diagnostic Report Years Considered

Figure 12. Global Alzheimer's Disease Blood Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Alzheimer's Disease Blood Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Alzheimer's Disease Blood Diagnostic Market Share by Region: 2023 VS 2030

Figure 15. Global Alzheimer's Disease Blood Diagnostic Market Share by Players in 2023

Figure 16. Global Top Alzheimer's Disease Blood Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Blood Diagnostic as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Alzheimer's Disease Blood Diagnostic Revenue in 2023

Figure 18. North America Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Alzheimer's Disease Blood Diagnostic Market Share by Country (2019-2030)

Figure 20. United States Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Alzheimer's Disease Blood Diagnostic Market Share by Country (2019-2030)

Figure 24. Germany Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Alzheimer's Disease Blood Diagnostic Market Share by Region (2019-2030)

Figure 32. China Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Alzheimer's Disease Blood Diagnostic Market Share by Country (2019-2030)

Figure 40. Mexico Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Alzheimer's Disease Blood Diagnostic Market Share by Country (2019-2030)

Figure 44. Turkey Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. UAE Alzheimer's Disease Blood Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Quanterix Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

Figure 48. C2N Diagnostics Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

Figure 49. Sysmex Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

Figure 50. Quest Diagnostics Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

Figure 51. Roche Diagnostics Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

Figure 52. Eli Lilly and Company Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

Figure 53. Fujirebio Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

Figure 54. Amoneta Diagnostics Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

Figure 55. MagQu Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

Figure 56. Vazyme Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

Figure 57. KingMed Diagnostics Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

Figure 58. Anqun Bioengineering Revenue Growth Rate in Alzheimer's Disease Blood Diagnostic Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions